Literature DB >> 12773978

Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients.

Yoshihiro Sakamoto1, Shigekazu Ohyama, Junji Yamamoto, Kazuhiko Yamada, Makoto Seki, Kei-ichiro Ohta, Norihiro Kokudo, Toshiharu Yamaguchi, Tetsuichiro Muto, Masatoshi Makuuchi.   

Abstract

BACKGROUND: The justification for surgical resection of liver metastases from gastric cancer remains controversial.
METHODS: Twenty-two patients who underwent 26 hepatectomies for liver metastases of gastric cancer between 1985 and 2001 were analyzed. Fifteen clinicopathologic factors were evaluated with univariate and multivariate analyses for survival after hepatic resection.
RESULTS: The overall 1-year, 3-year, and 5-year survival rates after hepatectomy for gastric metastases were 73%, 38%, and 38%, respectively. Five patients survived for more than 3 years without recurrence, 3 of whom had synchronous metastases resected at the time of gastrectomy. The best results after surgical resection for liver metastases of gastric cancer were obtained with solitary metastases less than 5 cm in size. The number of liver metastases (solitary or multiple) was the only significant prognostic factor according to both univariate and multivariate analyses.
CONCLUSION: Surgical resection for liver metastases of gastric cancer may be beneficial for patients with a solitary metastasis, whether it is synchronous or metachronous.

Entities:  

Mesh:

Year:  2003        PMID: 12773978     DOI: 10.1067/msy.2003.147

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  71 in total

Review 1.  Liver resections in metastatic gastric cancer.

Authors:  Sid P Kerkar; Clinton D Kemp; Itzhak Avital
Journal:  HPB (Oxford)       Date:  2010-11       Impact factor: 3.647

2.  Toxocariasis masquerading as liver and lung metastatic nodules in patents with gastrointestinal cancer: clinicopathologic study of five cases.

Authors:  Sanghui Park; Yun Soo Kim; Yu Jin Kim; Sun Young Kyung; Jeong-Woong Park; Sung Hwan Jeong; Sang Pyo Lee
Journal:  Dig Dis Sci       Date:  2011-08-11       Impact factor: 3.199

3.  Response to preoperative chemotherapy predicts survival in patients undergoing hepatectomy for liver metastases from gastric and esophageal cancer.

Authors:  Andreas Andreou; Luca Viganò; Giuseppe Zimmitti; Daniel Seehofer; Martin Dreyer; Andreas Pascher; Marcus Bahra; Wenzel Schoening; Volker Schmitz; Peter C Thuss-Patience; Timm Denecke; Gero Puhl; Jean-Nicolas Vauthey; Peter Neuhaus; Lorenzo Capussotti; Johann Pratschke; Sven-Christian Schmidt
Journal:  J Gastrointest Surg       Date:  2014-08-27       Impact factor: 3.452

Review 4.  Strategies for treating liver metastasis from gastric cancer.

Authors:  Yoshihiro Kakeji; Masaru Morita; Yoshihiko Maehara
Journal:  Surg Today       Date:  2010-03-26       Impact factor: 2.549

5.  Reported outcome factors for hepatic metastasectomy.

Authors:  N Joseph Espat
Journal:  J Gastrointest Surg       Date:  2006-02       Impact factor: 3.452

6.  Prognostic factors for survival in patients with hepatic recurrence after curative resection of gastric cancer.

Authors:  Si-Eun Hwang; Doo-Hyun Yang; Chan-Young Kim
Journal:  World J Surg       Date:  2009-07       Impact factor: 3.352

7.  Long-term survival after surgical resection for liver metastasis from gastric cancer: two case reports.

Authors:  Jong Keun Lim; Joong Bae Ahn; Sung Ha Cheon; Hyun Chang; Jong Yul Jung; Sun Young Rha; Jae Kyung Roh; Sung Hoon Noh; Ho Geun Kim; Hyun Cheol Chung; Hei-Cheul Jeung
Journal:  Cancer Res Treat       Date:  2006-06-30       Impact factor: 4.679

8.  High survival in patients operated for small isolated liver metastases from gastric cancer: a multi-institutional study.

Authors:  Koji Komeda; Michihiro Hayashi; Shoji Kubo; Hiroaki Nagano; Takuya Nakai; Masaki Kaibori; Hiroshi Wada; Shigekazu Takemura; Masahiko Kinoshita; Chikato Koga; Masataka Matsumoto; Tatsuma Sakaguchi; Yoshihiro Inoue; Fumitoshi Hirokawa; A-Hon Kwon; Kazuhisa Uchiyama
Journal:  World J Surg       Date:  2014-10       Impact factor: 3.352

9.  Weekly docetaxel and cisplatin plus fluorouracil as a preoperative treatment for gastric cancer patients with synchronous multiple hepatic metastases: a pilot study.

Authors:  Zi-Yu Li; Lei Tang; Lian-Hai Zhang; Zhao-De Bu; Ai-Wen Wu; Xiao-Jiang Wu; Xiang-Long Zong; Qi Wu; Fei Shan; Shuang-Xi Li; Hui Ren; Xiao-Peng Zhang; Jia-Fu Ji
Journal:  Med Oncol       Date:  2009-12-05       Impact factor: 3.064

10.  Analysis of the prognostic factors and evaluation of surgical treatment for synchronous liver metastases from gastric cancer.

Authors:  Kentaro Ueda; Makoto Iwahashi; Mikihito Nakamori; Masaki Nakamura; Teiji Naka; Koichiro Ishida; Toshiyasu Ojima; Hiroki Yamaue
Journal:  Langenbecks Arch Surg       Date:  2008-03-15       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.